Agenus Inc (AGEN)
11.91
+0.79
(+7.10%)
USD |
NASDAQ |
May 22, 16:00
11.90
-0.01
(-0.08%)
After-Hours: 20:00
Agenus Market Cap: 250.10M for May 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 22, 2024 | 250.10M |
| May 21, 2024 | 233.51M |
| May 20, 2024 | 224.69M |
| May 17, 2024 | 228.05M |
| May 16, 2024 | 220.49M |
| May 15, 2024 | 226.37M |
| May 14, 2024 | 224.69M |
| May 13, 2024 | 232.88M |
| May 10, 2024 | 220.28M |
| May 09, 2024 | 246.11M |
| May 08, 2024 | 240.86M |
| May 07, 2024 | 252.20M |
| May 06, 2024 | 271.94M |
| May 03, 2024 | 274.46M |
| May 02, 2024 | 262.85M |
| May 01, 2024 | 278.39M |
| April 30, 2024 | 254.45M |
| April 29, 2024 | 267.89M |
| April 26, 2024 | 245.43M |
| April 25, 2024 | 174.25M |
| April 24, 2024 | 155.78M |
| April 23, 2024 | 135.62M |
| April 22, 2024 | 121.14M |
| April 19, 2024 | 111.48M |
| April 18, 2024 | 104.34M |
| Date | Value |
|---|---|
| April 17, 2024 | 113.37M |
| April 16, 2024 | 131.96M |
| April 15, 2024 | 136.15M |
| April 12, 2024 | 170.71M |
| April 11, 2024 | 186.22M |
| April 10, 2024 | 187.31M |
| April 09, 2024 | 204.27M |
| April 08, 2024 | 195.46M |
| April 05, 2024 | 211.49M |
| April 04, 2024 | 212.42M |
| April 03, 2024 | 222.58M |
| April 02, 2024 | 214.98M |
| April 01, 2024 | 246.68M |
| March 28, 2024 | 242.97M |
| March 27, 2024 | 233.09M |
| March 26, 2024 | 224.71M |
| March 25, 2024 | 233.92M |
| March 22, 2024 | 228.77M |
| March 21, 2024 | 235.52M |
| March 20, 2024 | 232.33M |
| March 19, 2024 | 235.68M |
| March 18, 2024 | 221.90M |
| March 15, 2024 | 226.22M |
| March 14, 2024 | 251.23M |
| March 13, 2024 | 275.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
104.34M
Minimum
Apr 18 2024
1.516B
Maximum
Aug 30 2021
615.59M
Average
598.30M
Median
Apr 07 2021
Market Cap Benchmarks
| Ligand Pharmaceuticals Inc | 1.568B |
| Protalix BioTherapeutics Inc | 94.58M |
| InfuSystems Holdings Inc | 152.47M |
| PAVmed Inc | 16.98M |
| Allogene Therapeutics Inc | 555.37M |
Market Cap Related Metrics
| PS Ratio | 1.045 |
| Price | 11.91 |
| Earnings Yield | -591.6% |